Bain Is Said To Be Frontrunner For Indian Hospital Chain HCG
(Bloomberg) -- Bain Capital has emerged as the frontrunner to acquire a controlling stake in Indian cancer hospital chain HealthCare Global Enterprises Ltd., according to people familiar with the matter.
The US private equity firm is considering buying CVC Capital Partners' 60.4% stake in the Mumbai-listed company, said the people, who asked not to be identified as the information is private. Bain may consider paying a premium to the market price for the stake, the people said.
Shares of HCG, as the company is known, have lost roughly 3% this year, giving the company a market value of $589 million. CVC's stake would currently be worth about $356 million.
Deliberations are ongoing and talks could still fall apart, the people said. Other bidders could also emerge, they added. Representatives for Bain and CVC declined to comment, while HCG didn't respond to a request seeking comment.
The Busiest Corridors Leading to and From India: Bloomberg Deals
A growing middle class and rickety state-owned medical infrastructure have boosted demand for private medical services in India, accelerating deal activity in the health care sector. Last month, KKR & Co. agreed to buy a controlling stake Baby Memorial Hospital in Kerala for an undisclosed amount. Blackstone Inc. bought a controlling stake in two hospital chains, Care Hospitals and Kimshealth, in 2023.
Founded in 1989 in Bangalore, HCG owns 21 comprehensive cancer care centers across India and serves more than 200,000 patients every year, its website shows. CVC invested in the company in 2020.
More stories like this are available on bloomberg.com
©2024 Bloomberg L.P.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.